Health IT Analytics July 24, 2020
Jessica Kent

The state-of-the-art laboratory will use artificial intelligence algorithms to conduct molecular testing and accelerate precision medicine.

Hackensack Meridian Health (HMH) and Genomic Testing Cooperative (GTC) are launching a next generation sequencing reference laboratory that will use artificial intelligence to advance precision medicine.

The state-of-the-art laboratory will be located at JFK Medical Center in Edison, New Jersey, and will initially focus on cancer before expanding to immune diseases and various chronic conditions. The lab will bring genomics to the active screening and prevention program at HMH.

“Investing in genomics and establishing a reference laboratory in genomics represents a new phase for Hackensack Meridian Health and demonstrates our commitment to be a leader in improving patient care,” noted Robert C. Garrett, FACHE,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Pharma / Biotech, Precision Medicine, Technology
Revolutionizing Primary Care: The Role of Pharmacogenomics and AI in Personalized Medicine
BioAro Announces Real Time DNA Decoding Technology
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future

Share This Article